Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
暂无分享,去创建一个
S. Lehéricy | M. Chupin | P. Robert | J. Dartigues | M. Weiner | J. Darcourt | M. Zanca | K. Bennys | J. Touchon | M. Allard | C. Dufouil | P. Livet | P. Payoux | P. Legrand | S. Belleville | S. Andrieu | S. Chanalet | Y. Rolland | B. Vellas | N. Coley | S. Guyonnet | I. Carrié | L. Brigitte | C. Faisant | F. Lala | J. Delrieu | H. Villars | Emeline Combrouze | Carole Badufle | A. Zueras | C. Cantet | Christophe Morin | G. A. Kan | C. Dupuy | C. Caillaud | P. Ousset | B. Fougère | S. Willis | B. Gilbert | F. Fontaine | Isabelle Marcet | F. Delva | Sandrine Cerda | Corinne Costes | O. Rouaud | P. Manckoundia | V. Quipourt | S. Marilier | Evelyne Franon | L. Bories | Marie-Laure Pader | Marie-France Basset | Bruno Lapoujade | V. Faure | C. Malick-Loiseau | Evelyne Cazaban-Campistron | F. Desclaux | Colette Blatge | T. Dantoine | C. Laubarie-Mouret | I. Saulnier | J. Clément | M. Picat | L. Bernard-Bourzeix | S. Willebois | I. Desormais | Noëlle Cardinaud | M. Bonnefoy | P. Rebaudet | Claire Gédéon | Catherine Burdet | Flavien Terracol | Stephanie Roth | S. Chaillou | S. Louchart | K. Sudres | N. Lebrun | Nadège Barro-Belaygues | A. Gabelle | Aurélia Romano | Lynda Touati | C. Marelli | Cécile Pays | F. Duff | C. Gervais | S. Gonfrier | Y. Gasnier | S. Bordes | Danièle Begorre | Christian Carpuat | Khaled Khales | Jean-François Lefebvre | Samira Misbah El Idrissi | Pierre Skolil | J. Salles | Ali Bouhayia | F. Ricolfi | D. Dubois | F. Cotton | A. Bonafe | Françoise Hugon | F. Bonneville | C. Cognard | François Chollet | Sophie Peiffer | A. Hitzel | L. Molinier | H. Derumeaux | Christian Vincent | Bertrand Perret | C. Vinel | T. Voisin | J. F. Mangin | Alexandra Foubert | Alain Pesce | Jacques Monteil | J. Caubère | M. Cufi | Marie Noëlle-Cuffi | Michael Li | Yu-Ring Tong | M. Paule | Bonceour Martel | N. Costa | P. Olivier-Abbal | A. Pesce | P. Olivier‐Abbal | L. Bernard‐Bourzeix | N. Cardinaud | A. Romano | B. Perret | Claire Vinel | Valérie Faure | Cécile Laubarie-Mouret | Stéphanie Willebois | Pascale Rebaudet
[1] F. Askénazy,et al. Why an On-site Inpatient Pediatric Psychiatric Unit Is Needed to Improve Mental Health Care in the Pediatric Emergency Department of Lenval Hospital, Nice, France. , 2017, Pediatric emergency care.
[2] F. Askénazy. Les tribulations d’un pédopsychiatre en recherche clinique , 2017 .
[3] B. Vellas,et al. Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial , 2016, Alzheimer's & Dementia.
[4] L. Schneider,et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.
[5] Bruno Vellas,et al. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions , 2015, The Lancet Neurology.
[6] Lars Bäckman,et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.
[7] M. Pontecorvo,et al. Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[8] Nandini Raghavan,et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. , 2015, Journal of Alzheimer's disease : JAD.
[9] R. Sperling,et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. , 2014, JAMA neurology.
[10] M. Weiner,et al. MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA. , 2014, The journal of prevention of Alzheimer's disease.
[11] H. Amièva,et al. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. , 2014, Brain : a journal of neurology.
[12] Jennifer G. Robinson,et al. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes , 2014, Neurology.
[13] C. DeCarli,et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging , 2012, Neurology.
[14] Kewei Chen,et al. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. , 2011, Archives of neurology.
[15] S. Studenski,et al. Gait speed and survival in older adults. , 2011, JAMA.
[16] A. Blackwell,et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.
[17] Marcus Richards,et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.
[18] M. Inzitari,et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force , 2009, The journal of nutrition, health & aging.
[19] B. Fraysse,et al. Prevention of progression to dementia in the elderly: Rationale and proposal for a health-promoting memory consultation (an IANA task force) , 2008, The journal of nutrition, health & aging.
[20] A. Beekman,et al. Effect of fish oil on cognitive performance in older subjects , 2008, Neurology.
[21] S. Hercberg,et al. The French National Nutrition and Health Program: 2001–2006–2010 , 2008, International Journal of Public Health.
[22] F. Hu,et al. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. , 2007, The American journal of clinical nutrition.
[23] K. Markides,et al. Does 8‐Foot Walk Time Predict Cognitive Decline in Older Mexicans Americans? , 2007, Journal of the American Geriatrics Society.
[24] Rhoda Au,et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.
[25] D. Bennett,et al. ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical Trials , 2006, Alzheimer disease and associated disorders.
[26] Hilkka Soininen,et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.
[27] Jean-François Dartigues,et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.
[28] L. Ferrucci,et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[29] B. Heude,et al. Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.
[30] Suzanne G. Leveille,et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[31] Y. Joanette,et al. [Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level]. , 1990, Acta neurologica Belgica.
[32] Y. Hochberg. A sharper Bonferroni procedure for multiple tests of significance , 1988 .
[33] H. Buschke,et al. Screening for dementia by memory testing , 1988, Neurology.
[34] Lawton Mp. Scales to measure competence in everyday activities. , 1988 .
[35] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[36] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[37] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[38] S. Katz,et al. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.
[39] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .